82 research outputs found

    Police Action and the State-Created Danger Doctrine: a Proposed Uniform Test

    Get PDF
    The state-created danger doctrine provides the basis for a potential claim when a state actor creates a danger that results in an injury to the plaintiff. The doctrine may be interpreted as an exception to the general rule that a state has no duty to protect one private citizen from another. Because the U.S. Supreme Court has not addressed the issue, many variations of the state-created danger doctrine exist across the federal circuits. The resulting lack of uniformity has led to inconsistent results, promoting unfairness for litigants throughout the country. This Comment explores the history, objectives, and current approaches to the state-created danger doctrine. This Comment also examines the public policy considerations with which the federal circuits seem to struggle. A recent case involving police action demonstrates the perils of inconsistency and the need for balance to further the interests of the public. Finally, this Comment recommends a simplified uniform test to restore uniformity to the federal circuits

    Coordinated mm/sub-mm observations of Sagittarius A* in May 2007

    Get PDF
    At the center of the Milky Way, with a distance of ~8 kpc, the compact source Sagittarius A* (SgrA*) can be associated with a super massive black hole of ~4x10^6 solar masses. SgrA* shows strong variability from the radio to the X-ray wavelength domains. Here we report on simultaneous NIR/sub-millimeter/X-ray observations from May 2007 that involved the NACO adaptive optics (AO) instrument at the European Southern Observatory's Very Large Telescope, the Australian Telescope Compact Array (ATCA), the US mm-array CARMA, the IRAM 30m mm-telescope, and other telescopes. We concentrate on the time series of mm/sub-mm data from CARMA, ATCA, and the MAMBO bolometer at the IRAM 30m telescope.Comment: 7 pages, 3 figures, contribution for the conference "The Universe under the Microscope" (AHAR 2008), to be published in Journal of Physics: Conference Series by Institute of Physics Publishin

    Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

    Get PDF
    The emergence of the precision medicine paradigm in oncology has led to increasing interest in the integration of real-world data (RWD) into cancer clinical research. As sources of real-world evidence (RWE), such data could potentially help address the uncertainties that surround the adoption of novel anticancer therapies into the clinic following their investigation in clinical trials. At present, RWE-generating studies which investigate antitumour interventions seem to primarily focus on collecting and analysing observational RWD, typically forgoing the use of randomisation despite its methodological benefits. This is appropriate in situations where randomised controlled trials (RCTs) are not feasible and non-randomised RWD analyses can offer valuable insights. Nevertheless, depending on how they are designed, RCTs have the potential to produce strong and actionable RWE themselves. The choice of which methodology to employ for RWD studies should be guided by the nature of the research question they are intended to answer. Here, we attempt to define some of the questions that do not necessarily require the conduct of RCTs. Moreover, we outline the strategy of the European Organisation for Research and Treatment of Cancer (EORTC) to contribute to the generation of robust and high-quality RWE by prioritising the execution of pragmatic trials and studies set up according to the trials-within-cohorts approach. If treatment allocation cannot be left up to random chance due to practical or ethical concerns, the EORTC will consider undertaking observational RWD research based on the target trial principle. New EORTC-sponsored RCTs may also feature concurrent prospective cohorts composed of off-trial patients

    Defining the role of real-world data in cancer clinical research:The position of the European Organisation for Research and Treatment of Cancer

    Get PDF
    The emergence of the precision medicine paradigm in oncology has led to increasing interest in the integration of real-world data (RWD) into cancer clinical research. As sources of real-world evidence (RWE), such data could potentially help address the uncertainties that surround the adoption of novel anticancer therapies into the clinic following their investigation in clinical trials. At present, RWE-generating studies which investigate antitumour interventions seem to primarily focus on collecting and analysing observational RWD, typically forgoing the use of randomisation despite its methodological benefits. This is appropriate in situations where randomised controlled trials (RCTs) are not feasible and non-randomised RWD analyses can offer valuable insights. Nevertheless, depending on how they are designed, RCTs have the potential to produce strong and actionable RWE themselves. The choice of which methodology to employ for RWD studies should be guided by the nature of the research question they are intended to answer. Here, we attempt to define some of the questions that do not necessarily require the conduct of RCTs. Moreover, we outline the strategy of the European Organisation for Research and Treatment of Cancer (EORTC) to contribute to the generation of robust and high-quality RWE by prioritising the execution of pragmatic trials and studies set up according to the trials-within-cohorts approach. If treatment allocation cannot be left up to random chance due to practical or ethical concerns, the EORTC will consider undertaking observational RWD research based on the target trial principle. New EORTC-sponsored RCTs may also feature concurrent prospective cohorts composed of off-trial patients

    Traces of past activity in the Galactic Centre

    Full text link
    The Milky Way centre hosts a supermassive Black Hole (BH) with a mass of ~4*10^6 M_Sun. Sgr A*, its electromagnetic counterpart, currently appears as an extremely weak source with a luminosity L~10^-9 L_Edd. The lowest known Eddington ratio BH. However, it was not always so; traces of "glorious" active periods can be found in the surrounding medium. We review here our current view of the X-ray emission from the Galactic Center (GC) and its environment, and the expected signatures (e.g. X-ray reflection) of a past flare. We discuss the history of Sgr A*'s past activity and its impact on the surrounding medium. The structure of the Central Molecular Zone (CMZ) has not changed significantly since the last active phase of Sgr A*. This relic torus provides us with the opportunity to image the structure of an AGN torus in exquisite detail.Comment: Invited refereed review. Chapter of the book: "Cosmic ray induced phenomenology in star forming environments" (eds. Olaf Reimer and Diego F. Torres

    In situ formation of SgrA* stars via disk fragmentation: parent cloud properties and thermodynamics

    Full text link
    The formation of the massive young stars surrounding SgrA* is still an open question. In this paper, we simulate the infall of a turbulent molecular cloud towards the Galactic Center (GC). We adopt two different cloud masses (4.3x10^4 and 1.3x10^5 solar masses). We run five simulations: the gas is assumed to be isothermal in four runs, whereas radiative cooling is included in the fifth run. In all the simulations, the molecular cloud is tidally disrupted, spirals towards the GC, and forms a small, dense and eccentric disk around SgrA*. With high resolution simulations, we follow the fragmentation of the gaseous disk. Star candidates form in a ring at ~0.1-0.4 pc from the super-massive black hole (SMBH) and have moderately eccentric orbits (~0.2-0.4), in good agreement with the observations. The mass function of star candidates is top-heavy only if the local gas temperature is high (>~100 K) during the star formation and if the parent cloud is sufficiently massive (>~10^5 solar masses). Thus, this study indicates that the infall of a massive molecular cloud is a viable scenario for the formation of massive stars around SgrA*, provided that the gas temperature is kept sufficiently high (>~100 K).Comment: 16 pages, 16 figures, accepted for publication in Ap

    Star Formation and Dynamics in the Galactic Centre

    Full text link
    The centre of our Galaxy is one of the most studied and yet enigmatic places in the Universe. At a distance of about 8 kpc from our Sun, the Galactic centre (GC) is the ideal environment to study the extreme processes that take place in the vicinity of a supermassive black hole (SMBH). Despite the hostile environment, several tens of early-type stars populate the central parsec of our Galaxy. A fraction of them lie in a thin ring with mild eccentricity and inner radius ~0.04 pc, while the S-stars, i.e. the ~30 stars closest to the SMBH (<0.04 pc), have randomly oriented and highly eccentric orbits. The formation of such early-type stars has been a puzzle for a long time: molecular clouds should be tidally disrupted by the SMBH before they can fragment into stars. We review the main scenarios proposed to explain the formation and the dynamical evolution of the early-type stars in the GC. In particular, we discuss the most popular in situ scenarios (accretion disc fragmentation and molecular cloud disruption) and migration scenarios (star cluster inspiral and Hills mechanism). We focus on the most pressing challenges that must be faced to shed light on the process of star formation in the vicinity of a SMBH.Comment: 68 pages, 35 figures; invited review chapter, to be published in expanded form in Haardt, F., Gorini, V., Moschella, U. and Treves, A., 'Astrophysical Black Holes'. Lecture Notes in Physics. Springer 201

    Linking changes in species composition and biomass in a globally distributed grassland experiment

    Get PDF
    Global change drivers, such as anthropogenic nutrient inputs, are increasing globally. Nutrient deposition simultaneously alters plant biodiversity, species composition and ecosystem processes like aboveground biomass production. These changes are underpinned by species extinction, colonisation and shifting relative abundance. Here, we use the Price equation to quantify and link the contributions of species that are lost, gained or that persist to change in aboveground biomass in 59 experimental grassland sites. Under ambient (control) conditions, compositional and biomass turnover was high, and losses (i.e. local extinctions) were balanced by gains (i.e. colonisation). Under fertilisation, the decline in species richness resulted from increased species loss and decreases in species gained. Biomass increase under fertilisation resulted mostly from species that persist and to a lesser extent from species gained. Drivers of ecological change can interact relatively independently with diversity, composition and ecosystem processes and functions such as aboveground biomass due to the individual contributions of species lost, gained or persisting.Fil: Ladouceur, Emma. Martin Luther University Halle-Wittenberg; Alemania. Universitat Leipzig; Alemania. German Centre for Integrative Biodiversity Research (iDiv) Leipzig-Halle-Jena; AlemaniaFil: Blowes, Shane A.. Martin Luther University Halle-Wittenberg; Alemania. German Centre for Integrative Biodiversity Research (iDiv) Leipzig-Halle-Jena; AlemaniaFil: Chase, Jonathan M.. German Centre for Integrative Biodiversity Research (iDiv) Leipzig-Halle-Jena; Alemania. Martin Luther University Halle-Wittenberg; AlemaniaFil: Clark, Adam T.. Martin Luther University Halle-Wittenberg; Alemania. German Centre for Integrative Biodiversity Research (iDiv) Leipzig-Halle-Jena; Alemania. University of Graz; AustriaFil: Garbowski, Magda. German Centre for Integrative Biodiversity Research (iDiv) Leipzig-Halle-Jena; Alemania. Universitat Leipzig; AlemaniaFil: Alberti, Juan. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones Marinas y Costeras. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Investigaciones Marinas y Costeras; ArgentinaFil: Arnillas, Carlos Alberto. University of Toronto; CanadáFil: Bakker, Jonathan. University of Washington; Estados UnidosFil: Barrio, Isabel C.. Agricultural University of Iceland; IslandiaFil: Bharath, Siddharth. Atria University; IndiaFil: Borer, Elizabeth. University of Minnesota; Estados UnidosFil: Brudvig, Lars A.. Michigan State University; Estados UnidosFil: Cadotte, Marc W.. University of Toronto; CanadáFil: Chen, Qingqing. Peking University; ChinaFil: Collins, Scott L.. University of New Mexico; Estados UnidosFil: Dickman, Christopher R.. The University Of Sydney; AustraliaFil: Donohue, Ian. Trinity College Dublin; IrlandaFil: Du, Guozhen. Lanzhou University; ChinaFil: Ebeling, Anne. Universitat Jena; AlemaniaFil: Eisenhauer, Nico. Martin Luther University Halle—Wittenberg; Alemania. German Centre For Integrative Biodiversity Research (idiv) Halle-jena-leipzig; AlemaniaFil: Fay, Philip A.. USDA-ARS Grassland Soil and Water Research Lab; Estados UnidosFil: Hagenah, Nicole. University Of Pretoria; SudáfricaFil: Hautier, Yann. University of Utrecht; Países BajosFil: Jentsch, Anke. University of Bayreuth; AlemaniaFil: Jónsdóttir, Ingibjörg S.. University of Iceland; IslandiaFil: Komatsu, Kimberly J.. Smithsonian Environmental Research Center; Estados UnidosFil: MacDougall, Andrew. University of Guelph; CanadáFil: Martina, Jason P.. Texas State University; Estados UnidosFil: Moore, Joslin L.. Arthur Rylah Institute For Environmental Research; Australia. Monash University; AustraliaFil: Morgan, John W.. La Trobe University; AustraliaFil: Peri, Pablo Luis. Instituto Nacional de Tecnología Agropecuaria; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin

    Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer

    Get PDF
    The emergence of the precision medicine paradigm in oncology has led to increasing interest in the integration of real-world data (RWD) into cancer clinical research. As sources of real-world evidence (RWE), such data could potentially help address the uncertainties that surround the adoption of novel anticancer therapies into the clinic following their investigation in clinical trials. At present, RWE-generating studies which investigate antitumour interventions seem to primarily focus on collecting and analysing observational RWD, typically forgoing the use of randomisation despite its methodological benefits. This is appropriate in situations where randomised controlled trials (RCTs) are not feasible and non-randomised RWD analyses can offer valuable insights. Nevertheless, depending on how they are designed, RCTs have the potential to produce strong and actionable RWE themselves. The choice of which methodology to employ for RWD studies should be guided by the nature of the research question they are intended to answer. Here, we attempt to define some of the questions that do not necessarily require the conduct of RCTs. Moreover, we outline the strategy of the European Organisation for Research and Treatment of Cancer (EORTC) to contribute to the generation of robust and high-quality RWE by prioritising the execution of pragmatic trials and studies set up according to the trials-within-cohorts approach. If treatment allocation cannot be left up to random chance due to practical or ethical concerns, the EORTC will consider undertaking observational RWD research based on the target trial principle. New EORTC-sponsored RCTs may also feature concurrent prospective cohorts composed of off-trial patients
    corecore